News Headlines Article

Nation’s cancer chief appointed acting FDA commissioner
Washington Post

National Cancer Institute Director Norman “Ned” Sharpless will become acting commissioner of the Food and Drug Administration, Health and Human Services Secretary Alex Azar said Tuesday. Sharpless, 52, an accomplished researcher, oncologist and administrator, has been director of the cancer institute for about 18 months, earning good reviews from cancer advocates, patient groups and academic researchers. He will succeed Scott Gottlieb, who announced his resignation last week and with whom he has a cordial relationship. Gottlieb supported his appointment.